109 related articles for article (PubMed ID: 2978981)
1. [Oncogenes and oncogene products in urogenital cancer cells].
Deguchi N; Tachibana M; Tazaki H
Hum Cell; 1988 Mar; 1(1):20-4. PubMed ID: 2978981
[TBL] [Abstract][Full Text] [Related]
2. Molecular alterations associated with bladder cancer initiation and progression.
Cordon-Cardo C
Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathways of urothelial development and bladder tumorigenesis.
Castillo-Martin M; Domingo-Domenech J; Karni-Schmidt O; Matos T; Cordon-Cardo C
Urol Oncol; 2010; 28(4):401-8. PubMed ID: 20610278
[TBL] [Abstract][Full Text] [Related]
4. Promoter CpG hypermethylation and downregulation of XAF1 expression in human urogenital malignancies: implication for attenuated p53 response to apoptotic stresses.
Lee MG; Huh JS; Chung SK; Lee JH; Byun DS; Ryu BK; Kang MJ; Chae KS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG
Oncogene; 2006 Sep; 25(42):5807-22. PubMed ID: 16909101
[TBL] [Abstract][Full Text] [Related]
5. Comparative promoter methylation analysis of p53 target genes in urogenital cancers.
Christoph F; Hinz S; Weikert S; Kempkensteffen C; Schostak M; Miller K; Schrader M
Urol Int; 2008; 80(4):398-404. PubMed ID: 18587251
[TBL] [Abstract][Full Text] [Related]
6. [Molecular prognostic markers for urogenital cancers].
Kubota Y
Gan To Kagaku Ryoho; 1996 Jul; 23(8):997-1003. PubMed ID: 8687235
[TBL] [Abstract][Full Text] [Related]
7. Oncogene expression in prostate cancer.
Schalken JA; Bussemakers MJ; Debruyne FM
Prog Clin Biol Res; 1990; 357():97-105. PubMed ID: 2217484
[TBL] [Abstract][Full Text] [Related]
8. Genitourinary cancer predisposition syndromes.
Gallagher DJ; Feifer A; Coleman JA
Hematol Oncol Clin North Am; 2010 Oct; 24(5):861-83. PubMed ID: 20816578
[TBL] [Abstract][Full Text] [Related]
9. Oncogenes and oncoproteins as tumor markers.
Pillai R
Eur J Surg Oncol; 1992 Oct; 18(5):417-24. PubMed ID: 1426290
[TBL] [Abstract][Full Text] [Related]
10. Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization.
Richter J; Jiang F; Görög JP; Sartorius G; Egenter C; Gasser TC; Moch H; Mihatsch MJ; Sauter G
Cancer Res; 1997 Jul; 57(14):2860-4. PubMed ID: 9230190
[TBL] [Abstract][Full Text] [Related]
11. Alterations of tumor suppressor genes in bladder cancer.
Cordon-Cardo C; Reuter VE
Semin Diagn Pathol; 1997 May; 14(2):123-32. PubMed ID: 9179973
[TBL] [Abstract][Full Text] [Related]
12. Genetic alterations in urothelial bladder carcinoma: an updated review.
Mhawech-Fauceglia P; Cheney RT; Schwaller J
Cancer; 2006 Mar; 106(6):1205-16. PubMed ID: 16470587
[TBL] [Abstract][Full Text] [Related]
13. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
[TBL] [Abstract][Full Text] [Related]
14. [Clinical study of urinary cytology: with special reference to bladder cancer].
Nemoto S; Ishikawa S; Takeshima H; Iizumi T; Uchida K; Yazaki T; Nemoto R; Rinsho K; Kano S
Hinyokika Kiyo; 1983 Dec; 29(12):1611-5. PubMed ID: 6677108
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetics and biochemical mechanisms in bladder cancer. Oncogenes, tumor suppressor genes, and growth factors.
Sidransky D; Messing E
Urol Clin North Am; 1992 Nov; 19(4):629-39. PubMed ID: 1441021
[TBL] [Abstract][Full Text] [Related]
16. Expression of c-erbB-2 protein in normal and neoplastic urothelium: lack of adverse prognostic effect in human urinary bladder cancer.
Lee SE; Chow NH; Chi YC; Tzai TS; Yang WH; Lin SN
Anticancer Res; 1994; 14(3B):1317-24. PubMed ID: 7915094
[TBL] [Abstract][Full Text] [Related]
17. Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma.
Zhang ZT; Pak J; Shapiro E; Sun TT; Wu XR
Cancer Res; 1999 Jul; 59(14):3512-7. PubMed ID: 10416618
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a human, sex steroid-responsive transitional cell carcinoma maintained as a tumor line (R198) in athymic nude mice.
Reid LM; Leav I; Kwan PW; Russell P; Merk FB
Cancer Res; 1984 Oct; 44(10):4560-73. PubMed ID: 6467211
[TBL] [Abstract][Full Text] [Related]
19. Genitourinary tumor following kidney transplantation: a multicenter study.
Einollahi B; Simforoosh N; Lessan-Pezeshki M; Basiri A; Nafar M; Pour-Reza Gholi F; Firouzan A; Ahmadpour P; Makhdomi K; Ghafari A; Taghizadeh A; Tayebi Khosroshahi H
Transplant Proc; 2009 Sep; 41(7):2848-9. PubMed ID: 19765454
[TBL] [Abstract][Full Text] [Related]
20. Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis.
Paner GP; Barkan GA; Mehta V; Sirintrapun SJ; Tsuzuki T; Sebo TJ; Jimenez RE
Am J Surg Pathol; 2012 Mar; 36(3):432-42. PubMed ID: 22301493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
